Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Saved in:
| Title: | Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia. |
|---|---|
| Authors: | Ershova JV; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA. jhe3@cdc.gov., Volchenkov GV; Vladimir Oblast TB Dispensary, Vladimir, Russia., Somova TR; Vladimir Oblast TB Dispensary, Vladimir, Russia., Kuznetsova TA; Vladimir Oblast TB Dispensary, Vladimir, Russia., Kaunetis NV; Vladimir Oblast TB Dispensary, Vladimir, Russia., Kaminski D; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Demikhova OV; Central Tuberculosis Research Institute, Moscow, Russia., Chernousova LN; Central Tuberculosis Research Institute, Moscow, Russia., Vasilyeva IA; Central Tuberculosis Research Institute, Moscow, Russia., Kerr EM; Emory University, Atlanta, GA, USA., Cegielski JP; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Kurbatova EV; U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2020 Jul 25; Vol. 20 (1), pp. 543. Date of Electronic Publication: 2020 Jul 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
